Stryker has announced a new partnership with Brainomix that provides an option for European customers to purchase Brainomix’s e-Stroke software.
According to a press release from Stryker, the e-Stroke tool is an artificial intelligence (AI) powered software platform that provides real-time interpretation of brain scans, enabling physicians to more quickly diagnose stroke and make treatment and transfer decisions for patients. This allows more patients to get the right treatment in the right place, at the right time.
“We are pleased to hear about this new partnership between Brainomix and Stryker – who offer a complete and comprehensive stroke solution within their portfolio. The partnership with Brainomix will improve stroke patient care across Europe, the Middle East and Africa (EMEA),” said Markus Mӧhlenbruch, Interventional Neuroradiologist at Heidelberg University Hospital, Heidelberg, Germany.
“We are now able to offer customers software that can more quickly diagnose patients,” said Mark Paul, president of Stryker’s Neurovascular division, Salt Lake City, USA. “Helping our customers deliver the best possible outcomes for their patients is at the core of everything we do. With this partnership, we are able to facilitate the patient’s path to timely treatment, increasing the chance for a good outcome.”
Michalis Papadakis, CEO and co-founder of Brainomix, Oxford, UK, noted: “Partnerships have long played a key role for us at Brainomix, as a way of broadening our reach and expanding the solutions we can provide to hospitals. Together with Stryker we will be able to offer an end-to-end solution for hospitals, covering both imaging and treatment. We look forward to joining forces with Stryker Neurovascular, with whom we share a mutual commitment to improving stroke care by expanding patient access to life-saving treatments.”
